| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.90e-14 | 5 | 38 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 1.14e-13 | 6 | 38 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 8.17e-11 | 16 | 38 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 8.75e-10 | 103 | 38 | 7 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 9.17e-09 | 144 | 38 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | lysozyme activity | 1.92e-04 | 11 | 38 | 2 | GO:0003796 | |
| GeneOntologyMolecularFunction | peptidoglycan muralytic activity | 3.65e-04 | 15 | 38 | 2 | GO:0061783 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 9.48e-04 | 24 | 38 | 2 | GO:0005315 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 6.59e-07 | 10 | 38 | 3 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 7.46e-05 | 45 | 38 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.15e-04 | 9 | 38 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | clathrin-sculpted vesicle | 3.80e-04 | 16 | 38 | 2 | GO:0060198 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.47e-04 | 88 | 38 | 3 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcomere | 1.06e-03 | 249 | 38 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.16e-03 | 114 | 38 | 3 | GO:0016528 | |
| GeneOntologyCellularComponent | myofibril | 1.48e-03 | 273 | 38 | 4 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.85e-03 | 290 | 38 | 4 | GO:0043292 | |
| GeneOntologyCellularComponent | Z disc | 2.59e-03 | 151 | 38 | 3 | GO:0030018 | |
| MousePheno | enlarged thymus cortex | 3.85e-05 | 5 | 28 | 2 | MP:0013593 | |
| Domain | Aamy_C | 1.30e-11 | 4 | 37 | 4 | SM00632 | |
| Domain | Alpha_amylase | 1.30e-11 | 4 | 37 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 6.51e-11 | 5 | 37 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 6.51e-11 | 5 | 37 | 4 | IPR006048 | |
| Domain | Aamy | 4.54e-10 | 7 | 37 | 4 | SM00642 | |
| Domain | Alpha-amylase | 4.54e-10 | 7 | 37 | 4 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 4.54e-10 | 7 | 37 | 4 | IPR006047 | |
| Domain | A-amylase_C | 7.16e-09 | 3 | 37 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 1.75e-08 | 15 | 37 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 1.43e-07 | 6 | 37 | 3 | IPR015902 | |
| Domain | Glyco_hydro_catalytic_dom | 9.17e-07 | 38 | 37 | 4 | IPR013781 | |
| Domain | - | 2.57e-06 | 14 | 37 | 3 | 2.60.40.1180 | |
| Domain | Glycoside_hydrolase_SF | 3.56e-06 | 53 | 37 | 4 | IPR017853 | |
| Domain | LYZL1/LYZL2 | 3.82e-06 | 2 | 37 | 2 | IPR030057 | |
| Domain | Junctophilin | 2.29e-05 | 4 | 37 | 2 | IPR017191 | |
| Domain | - | 4.48e-05 | 35 | 37 | 3 | 3.20.20.80 | |
| Domain | Glyco_hydro_22_lys | 7.97e-05 | 7 | 37 | 2 | IPR000974 | |
| Domain | Glyco_hydro_22_CS | 7.97e-05 | 7 | 37 | 2 | IPR019799 | |
| Domain | LACTALBUMIN_LYSOZYME_2 | 1.06e-04 | 8 | 37 | 2 | PS51348 | |
| Domain | Lys | 1.06e-04 | 8 | 37 | 2 | PF00062 | |
| Domain | LACTALBUMIN_LYSOZYME_1 | 1.06e-04 | 8 | 37 | 2 | PS00128 | |
| Domain | LYZ1 | 1.06e-04 | 8 | 37 | 2 | SM00263 | |
| Domain | Glyco_hydro_22 | 1.06e-04 | 8 | 37 | 2 | IPR001916 | |
| Domain | Lysozyme-like_dom | 1.70e-04 | 10 | 37 | 2 | IPR023346 | |
| Domain | Pept_his_AS | 2.08e-04 | 11 | 37 | 2 | IPR025660 | |
| Domain | Pept_C1 | 2.94e-04 | 13 | 37 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 2.94e-04 | 13 | 37 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 2.94e-04 | 13 | 37 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 2.94e-04 | 13 | 37 | 2 | IPR013128 | |
| Domain | MORN | 3.42e-04 | 14 | 37 | 2 | SM00698 | |
| Domain | MORN | 3.95e-04 | 15 | 37 | 2 | PF02493 | |
| Domain | MORN | 3.95e-04 | 15 | 37 | 2 | IPR003409 | |
| Domain | THIOL_PROTEASE_CYS | 1.20e-03 | 26 | 37 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 1.30e-03 | 27 | 37 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 1.30e-03 | 27 | 37 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 1.40e-03 | 28 | 37 | 2 | IPR000169 | |
| Domain | MFS | 1.02e-02 | 77 | 37 | 2 | IPR011701 | |
| Domain | MFS_1 | 1.02e-02 | 77 | 37 | 2 | PF07690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 2.66e-12 | 9 | 28 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 9.71e-12 | 11 | 28 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 6.96e-10 | 23 | 28 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.02e-09 | 28 | 28 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.17e-08 | 52 | 28 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 3.90e-07 | 8 | 28 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 9.11e-06 | 21 | 28 | 3 | MM15526 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.57e-05 | 25 | 28 | 3 | MM15557 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 7.10e-15 | 6 | 38 | 5 | 6608795 | |
| Pubmed | 7.10e-15 | 6 | 38 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 7.10e-15 | 6 | 38 | 5 | 2788608 | |
| Pubmed | 7.10e-15 | 6 | 38 | 5 | 2081604 | ||
| Pubmed | 7.10e-15 | 6 | 38 | 5 | 15286789 | ||
| Pubmed | 6.62e-14 | 8 | 38 | 5 | 12414807 | ||
| Pubmed | 2.97e-13 | 10 | 38 | 5 | 9121556 | ||
| Pubmed | 5.44e-13 | 11 | 38 | 5 | 23449223 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 1.21e-12 | 4 | 38 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 1.21e-12 | 4 | 38 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 1.21e-12 | 4 | 38 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 1.21e-12 | 4 | 38 | 4 | 26098870 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 6160849 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 1.21e-12 | 4 | 38 | 4 | 4745489 | |
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 1.21e-12 | 4 | 38 | 4 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 1.21e-12 | 4 | 38 | 4 | 94264 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 3872721 | ||
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 1.21e-12 | 4 | 38 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 1.21e-12 | 4 | 38 | 4 | 6207174 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 2410924 | ||
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 1.21e-12 | 4 | 38 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 1.21e-12 | 4 | 38 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 1.21e-12 | 4 | 38 | 4 | 2987507 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 6091898 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 1.21e-12 | 4 | 38 | 4 | 2332419 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 1.21e-12 | 4 | 38 | 4 | 6162108 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 16152770 | ||
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 2423416 | ||
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 1.21e-12 | 4 | 38 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 1.21e-12 | 4 | 38 | 4 | 2989529 | |
| Pubmed | 6.05e-12 | 5 | 38 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 6.05e-12 | 5 | 38 | 4 | 34276419 | |
| Pubmed | 6.05e-12 | 5 | 38 | 4 | 6176569 | ||
| Pubmed | 6.05e-12 | 5 | 38 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 6.05e-12 | 5 | 38 | 4 | 8661735 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 1.81e-11 | 6 | 38 | 4 | 7859283 | |
| Pubmed | 1.81e-11 | 6 | 38 | 4 | 2002257 | ||
| Pubmed | 1.81e-11 | 6 | 38 | 4 | 2450406 | ||
| Pubmed | 1.81e-11 | 6 | 38 | 4 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 1.81e-11 | 6 | 38 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 1.81e-11 | 6 | 38 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 1.81e-11 | 6 | 38 | 4 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 1.81e-11 | 6 | 38 | 4 | 1021597 | |
| Pubmed | NEUROD1 reinforces endocrine cell fate acquisition in pancreatic development. | 1.81e-11 | 20 | 38 | 5 | 37689751 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 4.23e-11 | 7 | 38 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 4.23e-11 | 7 | 38 | 4 | 2451911 | |
| Pubmed | 4.23e-11 | 7 | 38 | 4 | 7949740 | ||
| Pubmed | 4.23e-11 | 7 | 38 | 4 | 6160178 | ||
| Pubmed | 4.23e-11 | 7 | 38 | 4 | 8604219 | ||
| Pubmed | 4.23e-11 | 7 | 38 | 4 | 8666240 | ||
| Pubmed | Insulin-promoter-factor 1 is required for pancreas development in mice. | 4.23e-11 | 7 | 38 | 4 | 7935793 | |
| Pubmed | 4.96e-11 | 24 | 38 | 5 | 22529374 | ||
| Pubmed | 6.19e-11 | 25 | 38 | 5 | 25918232 | ||
| Pubmed | 8.45e-11 | 8 | 38 | 4 | 2040456 | ||
| Pubmed | 8.45e-11 | 8 | 38 | 4 | 3038891 | ||
| Pubmed | 8.45e-11 | 8 | 38 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 8.45e-11 | 8 | 38 | 4 | 6200103 | |
| Pubmed | 8.45e-11 | 8 | 38 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 8.45e-11 | 8 | 38 | 4 | 7523515 | |
| Pubmed | 9.39e-11 | 27 | 38 | 5 | 8390965 | ||
| Pubmed | 1.52e-10 | 9 | 38 | 4 | 93520 | ||
| Pubmed | 1.52e-10 | 9 | 38 | 4 | 16423820 | ||
| Pubmed | 2.33e-10 | 32 | 38 | 5 | 25715394 | ||
| Pubmed | 2.53e-10 | 10 | 38 | 4 | 15280211 | ||
| Pubmed | 2.53e-10 | 10 | 38 | 4 | 2897103 | ||
| Pubmed | 3.97e-10 | 11 | 38 | 4 | 2565740 | ||
| Pubmed | 3.97e-10 | 11 | 38 | 4 | 7608209 | ||
| Pubmed | 3.97e-10 | 11 | 38 | 4 | 1617215 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 3.97e-10 | 11 | 38 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 3.97e-10 | 11 | 38 | 4 | 8589528 | |
| Pubmed | 3.97e-10 | 11 | 38 | 4 | 2903254 | ||
| Pubmed | 5.96e-10 | 12 | 38 | 4 | 11044404 | ||
| Pubmed | Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. | 5.96e-10 | 12 | 38 | 4 | 10471501 | |
| Pubmed | 5.96e-10 | 12 | 38 | 4 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 8.60e-10 | 13 | 38 | 4 | 7829080 | |
| Pubmed | Expression profile of MODY3/HNF-1alpha protein in the developing mouse pancreas. | 8.60e-10 | 13 | 38 | 4 | 12189445 | |
| Pubmed | 8.60e-10 | 13 | 38 | 4 | 489953 | ||
| Pubmed | Foxa2 is required for the differentiation of pancreatic alpha-cells. | 1.20e-09 | 14 | 38 | 4 | 15680365 | |
| Pubmed | 1.20e-09 | 14 | 38 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 1.20e-09 | 14 | 38 | 4 | 8001974 | |
| Pubmed | 1.20e-09 | 14 | 38 | 4 | 16418487 | ||
| Pubmed | 1.20e-09 | 14 | 38 | 4 | 2902233 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.20e-09 | 3 | 38 | 3 | 2413838 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 6098446 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.20e-09 | 3 | 38 | 3 | 21827821 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 30982860 | ||
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.20e-09 | 3 | 38 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.20e-09 | 3 | 38 | 3 | 2436036 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.20e-09 | 3 | 38 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.20e-09 | 3 | 38 | 3 | 17223109 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 15299664 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 12527308 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 2414282 | ||
| Interaction | AMY2B interactions | 6.78e-07 | 10 | 37 | 3 | int:AMY2B | |
| Interaction | HTN3 interactions | 2.24e-05 | 30 | 37 | 3 | int:HTN3 | |
| Cytoband | 1p21 | 1.24e-11 | 24 | 38 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 2.95e-08 | 107 | 38 | 5 | chr1p21 | |
| Cytoband | 10p11.23 | 1.01e-04 | 18 | 38 | 2 | 10p11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p12 | 2.17e-04 | 140 | 38 | 3 | chr10p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q23 | 6.90e-03 | 150 | 38 | 2 | chr12q23 | |
| GeneFamily | Lysozymes, c-type | 7.11e-05 | 9 | 26 | 2 | 1174 | |
| GeneFamily | Cathepsins | 2.06e-04 | 15 | 26 | 2 | 470 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 3.66e-07 | 41 | 38 | 4 | MM698 | |
| Coexpression | BERGER_MBD2_TARGETS | 4.60e-07 | 11 | 38 | 3 | MM905 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 1.73e-06 | 60 | 38 | 4 | MM654 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.96e-06 | 143 | 38 | 5 | MM1056 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP | 4.07e-06 | 166 | 38 | 5 | MM563 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 7.48e-06 | 330 | 38 | 6 | MM1120 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 8.03e-06 | 27 | 38 | 3 | MM643 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.18e-05 | 97 | 38 | 4 | MM1016 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 2.19e-05 | 399 | 38 | 6 | M41172 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 2.39e-05 | 116 | 38 | 4 | MM1240 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 3.97e-05 | 132 | 38 | 4 | MM470 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_UP | 6.63e-05 | 54 | 38 | 3 | MM889 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 7.22e-05 | 302 | 38 | 5 | MM1046 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 7.79e-05 | 57 | 38 | 3 | MM527 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 1.47e-04 | 185 | 38 | 4 | MM1072 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HMGL | 1.68e-04 | 577 | 38 | 6 | M39051 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP | 1.98e-04 | 200 | 38 | 4 | M7322 | |
| Coexpression | GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | 1.98e-04 | 200 | 38 | 4 | M7133 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN | 1.98e-04 | 200 | 38 | 4 | M3831 | |
| Coexpression | LEIN_MIDBRAIN_MARKERS | 2.83e-04 | 88 | 38 | 3 | MM717 | |
| Coexpression | HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN | 3.66e-04 | 96 | 38 | 3 | MM1009 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 3.90e-04 | 239 | 38 | 4 | MM1274 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.67e-06 | 153 | 38 | 4 | 3570dd844d6479425bf6f62129f88efa45553775 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-05 | 160 | 38 | 4 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 1.09e-05 | 162 | 38 | 4 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-05 | 182 | 38 | 4 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 184 | 38 | 4 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-05 | 187 | 38 | 4 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.12e-05 | 192 | 38 | 4 | fcdb2e924800457d21e4aaeeedd81dbf80216eed | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-05 | 198 | 38 | 4 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | BAL-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.44e-05 | 199 | 38 | 4 | 0f0fcc6fb980167cfa9aa404b845441fb95a08f4 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 2.44e-05 | 199 | 38 | 4 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 2.44e-05 | 199 | 38 | 4 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | BAL-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.44e-05 | 199 | 38 | 4 | 3662ed5d929ab64293e65f33dabcefc3458a08e5 | |
| ToppCell | Mild-Myeloid-Macrophages|Mild / Condition, Lineage, Cell class and cell subclass | 2.44e-05 | 199 | 38 | 4 | d8a00e6aecc4bfd1f868f1ee54bcfa820401efaf | |
| ToppCell | Mild_COVID-19-Myeloid|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.44e-05 | 199 | 38 | 4 | c0a9f5629db5beff7c07c9d111a7707e062d746f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 199 | 38 | 4 | f987f48970aec46156b80656e49b9f3604f3758c | |
| ToppCell | Mild-Myeloid|Mild / Condition, Lineage, Cell class and cell subclass | 2.44e-05 | 199 | 38 | 4 | 0678e50ffda664fb76681a1ee9021deab73bf850 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.44e-05 | 199 | 38 | 4 | 78db2e3b85356ed2f08794e5a97c16a220f8a076 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.48e-05 | 200 | 38 | 4 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 200 | 38 | 4 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / Condition, Lineage and Cell class | 2.48e-05 | 200 | 38 | 4 | 4c9e936b5e100c1a3ef10ea262febccf8226df9f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.48e-05 | 200 | 38 | 4 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.48e-05 | 200 | 38 | 4 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-04 | 124 | 38 | 3 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.25e-04 | 139 | 38 | 3 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.44e-04 | 143 | 38 | 3 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.65e-04 | 147 | 38 | 3 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 151 | 38 | 3 | a306e8dac653bc785d805d8d2d94feec3cb01727 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.98e-04 | 153 | 38 | 3 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.21e-04 | 157 | 38 | 3 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-04 | 158 | 38 | 3 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.34e-04 | 159 | 38 | 3 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Frontal_cortex-Hematopoietic|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.40e-04 | 160 | 38 | 3 | 70ffbe61cfd729519b23569a43d929b117ab8d5e | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 3.46e-04 | 161 | 38 | 3 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 161 | 38 | 3 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 161 | 38 | 3 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.46e-04 | 161 | 38 | 3 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.52e-04 | 162 | 38 | 3 | 7c73fe8388af370461e04097cf145cbc9847285b | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-04 | 165 | 38 | 3 | 8d3d5860a4785c4908160ae5fcb421ee80bd78ce | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-04 | 165 | 38 | 3 | 17ee6f269ed8d378465cf00ca59d48d8b106808e | |
| ToppCell | facs-Heart-LA-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 166 | 38 | 3 | 19ec59f0a43d4eb5b4cc7bcd6480ada7f469054b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 168 | 38 | 3 | 26fce414439ccd204e3acb41f2b4f75072df5a26 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 168 | 38 | 3 | 61a5435b27b01ff1a509ea463a6af220c5d2c9b3 | |
| ToppCell | TCGA-Pancreas|World / Sample_Type by Project: Shred V9 | 3.92e-04 | 168 | 38 | 3 | 279d5fcf9bd3f56ab560e37eed6fb3bd57dd93de | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-04 | 169 | 38 | 3 | 6a2ef66d7ff69a92e8c62759482e823a07352440 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-04 | 169 | 38 | 3 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-04 | 169 | 38 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.06e-04 | 170 | 38 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 171 | 38 | 3 | 9fc43a72291f086833dbf426d2375b30a424abe1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-04 | 171 | 38 | 3 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-04 | 171 | 38 | 3 | ef9397cec7f5c217d34583f26270af7ed7fbcebf | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-04 | 172 | 38 | 3 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-04 | 172 | 38 | 3 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.20e-04 | 172 | 38 | 3 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-04 | 172 | 38 | 3 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-04 | 172 | 38 | 3 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-04 | 172 | 38 | 3 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-04 | 172 | 38 | 3 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-04 | 173 | 38 | 3 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-04 | 173 | 38 | 3 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.27e-04 | 173 | 38 | 3 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.27e-04 | 173 | 38 | 3 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.27e-04 | 173 | 38 | 3 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.27e-04 | 173 | 38 | 3 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.27e-04 | 173 | 38 | 3 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.27e-04 | 173 | 38 | 3 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 4.34e-04 | 174 | 38 | 3 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 175 | 38 | 3 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 175 | 38 | 3 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 175 | 38 | 3 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 3c3b6c02d7acdc1305878ee34e9cbabbf9e87892 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 7c743b7e954c1ebfa289ed529abacb88504112ea | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-04 | 176 | 38 | 3 | d09e28606e2a6ed1f660898316765ca215085c18 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.49e-04 | 176 | 38 | 3 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 60740f676db5d259ef3046bd5bc7b7b14924ecee | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.56e-04 | 177 | 38 | 3 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 4.64e-04 | 178 | 38 | 3 | 11a338032b59b936c5e65517c4160f7dd47a2cda | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 179 | 38 | 3 | c4ff8b191ed0f6dc2dd784869f6f2c62e170a7db | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 179 | 38 | 3 | a79a244bf8ecc333d034b2eb2de554d3310ca6de | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 179 | 38 | 3 | dc03b9045510eb1bb934329646bb92dd06890ce9 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 4.72e-04 | 179 | 38 | 3 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 179 | 38 | 3 | 330c1326ba93bb8f32559ee1cc40e357cc44ad8d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.72e-04 | 179 | 38 | 3 | 06d412fc096d88de168969466ce422f0ab5553b2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-04 | 179 | 38 | 3 | 6624a2e731ab2d6c2eec19445e3dc509f581a8a9 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.79e-04 | 180 | 38 | 3 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 181 | 38 | 3 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-04 | 181 | 38 | 3 | a52e367f0909689174b3534f0cd51f36abe1b49f | |
| ToppCell | Control-Myeloid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-04 | 181 | 38 | 3 | 25170e5285996cc80337d5f86a0255569861ae77 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.95e-04 | 182 | 38 | 3 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.03e-04 | 183 | 38 | 3 | 36b194e366a14ebc4df187bf31c902be3797bfcc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 183 | 38 | 3 | 9533db4db2c6ae78d7ca1682cf4efed12183396f | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.03e-04 | 183 | 38 | 3 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 183 | 38 | 3 | bf7f1cb55ed55981b8b355d5774055c96e658ff2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.03e-04 | 183 | 38 | 3 | 745271bfe15e94a58157cd97d771e610f964341b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-04 | 183 | 38 | 3 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.11e-04 | 184 | 38 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.11e-04 | 184 | 38 | 3 | 840fac463665ed18752f402f7d1ef2e5052bdf74 | |
| ToppCell | facs-Bladder-nan-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | 3e00879466e626aa8604efecfc4678d64f54dbfc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | 3dc5812c961ff209f197ff4cbfb90009c0537550 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-04 | 186 | 38 | 3 | 948815663c212c4311329d503b5991cbbbff9808 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.71e-05 | 50 | 19 | 3 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 5.90e-14 | 6 | 38 | 5 | CID003083414 | |
| Drug | R 623 | 5.90e-14 | 6 | 38 | 5 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 5.90e-14 | 6 | 38 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 5.90e-14 | 6 | 38 | 5 | CID000127364 | |
| Drug | CNP-G3 | 5.90e-14 | 6 | 38 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 2.06e-13 | 7 | 38 | 5 | CID000174858 | |
| Drug | BG5P | 2.06e-13 | 7 | 38 | 5 | CID003082752 | |
| Drug | desethylaprophen | 5.50e-13 | 8 | 38 | 5 | CID000163919 | |
| Drug | azintamide | 5.50e-13 | 8 | 38 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 1.24e-12 | 9 | 38 | 5 | CID000194237 | |
| Drug | trestatin A | 1.24e-12 | 9 | 38 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 2.47e-12 | 10 | 38 | 5 | CID000485275 | |
| Drug | I ZE | 2.47e-12 | 10 | 38 | 5 | CID009549200 | |
| Drug | Glc)4 | 2.47e-12 | 10 | 38 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 2.47e-12 | 10 | 38 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 2.47e-12 | 10 | 38 | 5 | CID000118008 | |
| Drug | validamycin D | 4.52e-12 | 11 | 38 | 5 | CID000166726 | |
| Drug | FG5P | 4.52e-12 | 11 | 38 | 5 | CID000127486 | |
| Drug | CNP-G5 | 4.52e-12 | 11 | 38 | 5 | CID000127309 | |
| Drug | HgI2 | 4.52e-12 | 11 | 38 | 5 | CID000024485 | |
| Drug | 2C KM | 4.52e-12 | 11 | 38 | 5 | CID009549196 | |
| Drug | 2-nitropropyl acetate | 6.59e-12 | 4 | 38 | 4 | CID013573844 | |
| Drug | N-PMT | 6.59e-12 | 4 | 38 | 4 | CID000194224 | |
| Drug | Dembrexine | 6.59e-12 | 4 | 38 | 4 | CID000072009 | |
| Drug | g lw | 6.59e-12 | 4 | 38 | 4 | CID000444139 | |
| Drug | AC1MQT4V | 6.59e-12 | 4 | 38 | 4 | CID003482066 | |
| Drug | beta-santalene | 6.59e-12 | 4 | 38 | 4 | CID000010534 | |
| Drug | SAIB-SG | 6.59e-12 | 4 | 38 | 4 | CID002735139 | |
| Drug | azaprophen | 7.73e-12 | 12 | 38 | 5 | CID000129486 | |
| Drug | methyl 1'-epiacarviosin | 1.26e-11 | 13 | 38 | 5 | CID000197426 | |
| Drug | isoacarbose | 1.26e-11 | 13 | 38 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 1.95e-11 | 14 | 38 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 1.95e-11 | 14 | 38 | 5 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 1.95e-11 | 14 | 38 | 5 | CID000012074 | |
| Drug | 4-nitrophenylmaltoheptaoside | 2.92e-11 | 15 | 38 | 5 | CID000173254 | |
| Drug | actinidine | 3.29e-11 | 5 | 38 | 4 | CID000068231 | |
| Drug | Deposiston | 3.29e-11 | 5 | 38 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 3.29e-11 | 5 | 38 | 4 | CID010358258 | |
| Drug | 2TAA | 3.29e-11 | 5 | 38 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 3.29e-11 | 5 | 38 | 4 | CID006449879 | |
| Drug | silver perchlorate | 3.29e-11 | 5 | 38 | 4 | CID000024562 | |
| Drug | lunularic acid | 3.29e-11 | 5 | 38 | 4 | CID000161413 | |
| Drug | himachalene | 3.29e-11 | 5 | 38 | 4 | CID000015095 | |
| Drug | AC1L4DZ4 | 3.29e-11 | 5 | 38 | 4 | CID000155287 | |
| Drug | gamma-cyclodextrin | 4.25e-11 | 16 | 38 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 4.25e-11 | 16 | 38 | 5 | CID003085308 | |
| Drug | trimitan | 8.31e-11 | 18 | 38 | 5 | CID000005561 | |
| Drug | aprophen | 8.31e-11 | 18 | 38 | 5 | CID000071128 | |
| Drug | 2-amino-6-picoline | 9.87e-11 | 6 | 38 | 4 | CID000015765 | |
| Drug | phenol blue | 9.87e-11 | 6 | 38 | 4 | CID000075078 | |
| Drug | Gu-4 | 9.87e-11 | 6 | 38 | 4 | CID000448679 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 9.87e-11 | 6 | 38 | 4 | CID009577343 | |
| Drug | Borane dimethylamine complex | 9.87e-11 | 6 | 38 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 9.87e-11 | 6 | 38 | 4 | CID000092801 | |
| Drug | AC1OAGH8 | 9.87e-11 | 6 | 38 | 4 | CID006857368 | |
| Drug | vermella | 9.87e-11 | 6 | 38 | 4 | CID000203726 | |
| Drug | hymenin | 9.87e-11 | 6 | 38 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 9.87e-11 | 6 | 38 | 4 | CID000011615 | |
| Drug | kasugamycin | 1.46e-10 | 47 | 38 | 6 | CID000065174 | |
| Drug | AC1L3XPY | 1.97e-10 | 21 | 38 | 5 | CID000124005 | |
| Drug | 3KBG5CNP | 2.30e-10 | 7 | 38 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 2.30e-10 | 7 | 38 | 4 | CID000071762 | |
| Drug | Paramax | 2.30e-10 | 7 | 38 | 4 | CID000156411 | |
| Drug | methyl blue | 2.30e-10 | 7 | 38 | 4 | CID011969534 | |
| Drug | amino-methyl | 2.30e-10 | 7 | 38 | 4 | CID000142005 | |
| Drug | maltosaccharide | 2.54e-10 | 22 | 38 | 5 | CID005461034 | |
| Drug | pentylamine | 3.10e-10 | 53 | 38 | 6 | CID000008060 | |
| Drug | Panose B | 4.09e-10 | 24 | 38 | 5 | CID000439297 | |
| Drug | boric acid gel | 4.59e-10 | 8 | 38 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 4.59e-10 | 8 | 38 | 4 | CID005317411 | |
| Drug | theodrenaline | 4.59e-10 | 8 | 38 | 4 | CID000071857 | |
| Drug | N-vinylcaprolactam | 4.59e-10 | 8 | 38 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 4.59e-10 | 8 | 38 | 4 | CID000146692 | |
| Drug | acrinor | 4.59e-10 | 8 | 38 | 4 | CID005489637 | |
| Drug | rhodanile blue | 4.59e-10 | 8 | 38 | 4 | CID000073372 | |
| Drug | NSC300622 | 4.59e-10 | 8 | 38 | 4 | CID000028426 | |
| Drug | CID439354 | 5.11e-10 | 25 | 38 | 5 | CID000439354 | |
| Drug | C13H9cl2NO5 | 7.74e-10 | 27 | 38 | 5 | CID004369477 | |
| Drug | AC1L1I1P | 8.20e-10 | 62 | 38 | 6 | CID000004385 | |
| Drug | Atonik | 8.26e-10 | 9 | 38 | 4 | CID000069471 | |
| Drug | GSAD | 8.26e-10 | 9 | 38 | 4 | CID009909127 | |
| Drug | GU-3 | 8.26e-10 | 9 | 38 | 4 | CID000448687 | |
| Drug | zingiberene | 8.26e-10 | 9 | 38 | 4 | CID000092776 | |
| Drug | H 187 | 8.26e-10 | 9 | 38 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 8.26e-10 | 9 | 38 | 4 | CID000024864 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 1.36e-09 | 30 | 38 | 5 | CID005373003 | |
| Drug | orcein | 1.36e-09 | 30 | 38 | 5 | CID005386447 | |
| Drug | trans-cinnamamide | 1.37e-09 | 10 | 38 | 4 | CID000012135 | |
| Drug | CG-120 | 1.37e-09 | 10 | 38 | 4 | CID000171403 | |
| Drug | naphthalene-1,3,6,8-tetrol | 1.37e-09 | 10 | 38 | 4 | CID000440202 | |
| Drug | eicosa-11,14-dienoic acid | 1.37e-09 | 10 | 38 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 1.37e-09 | 10 | 38 | 4 | CID000126789 | |
| Drug | N-bromosuccinimide | 1.59e-09 | 69 | 38 | 6 | CID000067184 | |
| Drug | Folin Marenzi reagent | 1.92e-09 | 32 | 38 | 5 | CID000452313 | |
| Drug | AMO-1618 | 2.16e-09 | 11 | 38 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 2.16e-09 | 11 | 38 | 4 | CID000430710 | |
| Drug | Tempamine | 2.16e-09 | 11 | 38 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 2.16e-09 | 11 | 38 | 4 | CID000164608 | |
| Drug | R625 | 2.26e-09 | 33 | 38 | 5 | CID000072375 | |
| Drug | PNPC | 3.08e-09 | 35 | 38 | 5 | CID000165125 | |
| Disease | alpha-amylase 1 measurement | 2.62e-10 | 9 | 37 | 4 | EFO_0801371 | |
| Disease | intestinal permeability measurement | 4.88e-04 | 26 | 37 | 2 | EFO_0011031 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 1.10e-03 | 39 | 37 | 2 | DOID:9744 (implicated_via_orthology) | |
| Disease | dental caries | 1.66e-03 | 187 | 37 | 3 | EFO_0003819 | |
| Disease | vitamin D measurement, COVID-19 | 1.73e-03 | 49 | 37 | 2 | EFO_0004631, MONDO_0100096 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.87e-03 | 195 | 37 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | facial morphology | 2.18e-03 | 55 | 37 | 2 | EFO_0004743 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEKMSYLKNWGEGWG | 286 | P0DTE7 | |
| GEKMSYLKNWGEGWG | 286 | P0DTE8 | |
| GEKMSYLKNWGEGWG | 286 | P0DUB6 | |
| GEKMSYLKNWGEGWG | 286 | P19961 | |
| WGHMMGDEGSAYWIA | 146 | Q9UJ70 | |
| MEEGKGHYGPQCDWW | 246 | Q6DT37 | |
| GEKMSYLKNWGEGWG | 286 | P04746 | |
| GDVTTHGWYGWVKKE | 16 | O75884 | |
| KYKIWMHVDAAWGGG | 356 | Q05329 | |
| QGMNYWQGWKKHCEG | 121 | Q6UWQ5 | |
| QGMNYWQGWKKHCEG | 121 | Q7Z4W2 | |
| LQYKADLAWMKGVGW | 681 | Q86VF7 | |
| TKGKWMYRGEWSHGF | 76 | Q9HDC5 | |
| KAHAWKGQWAGGAYA | 126 | P52945 | |
| GEKGARGWKAWMHQQ | 531 | Q9H7Z3 | |
| MDLVWSAWYGKCVKG | 16 | Q9Y4W2 | |
| GDGKYGAWKNGHWTG | 601 | Q8TCU5 | |
| WFGKGKRGFIMGIWN | 171 | Q8TED4 | |
| WMDHGGWYDRKIIGA | 2316 | Q9P2D7 | |
| AGKWCYKGHCMWKNA | 531 | O15072 | |
| GKMWSPKSGWADAKY | 271 | P42357 | |
| FIGHDWGGMLVWYMA | 331 | P34913 | |
| KWSMDKLANGWIYGE | 2731 | Q92736 | |
| DGGWTPMIWATEYKH | 871 | Q9H9B1 | |
| YVLWRKKWHAKGFGM | 286 | Q8N1G2 | |
| MKGKDGYWADRGCEW | 466 | P22897 | |
| SQHGGKWPYWFKKME | 766 | A6NHR9 | |
| FGSWFDHIKGWLRMK | 186 | O00204 | |
| EWYGIKGMQAHWIGD | 261 | Q15031 | |
| FMVRKAMGGHWPFGW | 81 | P21462 | |
| MEKGGKGWHKAWFVV | 831 | P98174 | |
| RKVKHGHFGWPGWEM | 186 | Q13501 | |
| SWGEEWGMGGYVKMA | 301 | P07711 | |
| WGSSWGVDGYAHVKM | 291 | P43234 | |
| DSWLIKGLMYGGVWA | 326 | Q8IUH5 | |
| KWAFVHWYVGEGMEE | 401 | Q6PEY2 | |
| EGVTYPACHGMWSKW | 196 | Q8NDX2 | |
| ESKGKWVYKGEWTHG | 76 | Q8WXH2 |